Objective: We report our experience with repair of tetralogy of Fallot associated with complete atrioventricular septal defect, addressing in particular the need for a pulmonary valve in the right ventricular outflow tract.
Objective: We report our experience with repair of tetralogy of Fallot associated with complete atrioventricular septal defect, addressing in particular the need for a pulmonary valve in the right ventricular outflow tract.
Methods: Between 1992 and 2006, 33 children with tetralogy of Fallot and complete atrioventricular septal defect were admitted; 26 had Down's syndrome (79%). Thirty-two children had complete repair (18 primary, 14 staged); of the 15 who received initial palliation, 1 died before complete repair. Right ventricular outflow tract obstruction was relieved by transannular patch in 14 cases (42%), infundibular patch with preservation of the pulmonary valve in 7 (21%), and right ventricle-to-pulmonary artery conduit in 11 (33%).
Results: There were no hospital deaths. Actuarial survival was 96% AE 3.9% at 5 years and 85.9 AE 1.1% at 10 years. Multivariate analysis showed that type of relief of right ventricular outflow tract obstruction did not influence survival (P ¼ .16), nor did the choice to use a valved conduit (P ¼ .82). Primary correction (P ¼ .05) and lower weight at repair (P ¼ .05) were associated with higher probability of survival. Mean follow-up was 69.3 AE 5.9 months (range 0.2-282 months). There were 2 late deaths. Overall freedom from reoperation was 69% at 5 years and 38% at 10 years. Right ventricular outflow tract reconstruction without use of a valved conduit allowed a significantly higher freedom from reinterventions (P < .05).
Conclusions:
Tetralogy of Fallot associated with complete atrioventricular septal defect can be corrected at low risk with favorable intermediate survival. Use of right ventricle-to-pulmonary artery conduit can be avoided in two thirds of patients with no impact on survival, possibly improving overall freedom from reintervention.
The association of tetralogy of Fallot (TOF) with complete atrioventricular septal defect (CAVSD) is rare 1,2 ; it was detected in 5% of patients having CAVSD repair and in 1.7% of patients having TOF repair. [2] [3] [4] This anatomic complex exhibits combined, though distinctive, morphologic features of CAVSD and TOF. 5 Initial experiences with surgical correction of this anomaly were affected by high mortality, 4, 6, 7 but technical advances have led to better outcomes. 3, 8 However, the need for a valved reconstruction of the right ventricular outflow tract (RVOT) still remains undefined. This report shows the dispensability of a pulmonary valve in TOF-CAVSD repair.
MATERIALS AND METHODS
Between 1992 and 2006, 33 consecutive children with CAVSD associated with TOF were referred to Bambino Gesù Pediatric Hospital, Rome, Italy. Excluded from this analysis were children with unbalanced CAVSDs requiring univentricular repair and those with atrioventricular or ventriculoarterial discordance.
After parental consent was obtained, a retrospective review of all medical records was carried out. Follow-up data were obtained from outpatient clinic records or by contact with the referring physicians. Functional status was assessed according to the New York Heart Association classification. The study was approved by the local Ethics Committee.
Surgical Technique
Repair was accomplished by standard cardiopulmonary bypass with bicaval cannulation, mild to moderate hypothermia (28 C-32 C), and intermittent infusion of antegrade blood cardioplegic solution. All preexisting shunts were divided at initiation of cardiopulmonary bypass.
All children had closure of septal defects using the 2-patch technique. The ventricular patch was made of glutaraldehyde-treated autologous or heterologous pericardium and was shaped like a comma. Closure of the anterosuperior extension of the ventricular septal defect was facilitated by exposure through a right infundibular incision. The cleft of the left atrioventricular valve was closed with multiple interrupted monofilament sutures, and competence of the valve was assessed by filling the left ventricle with cold saline solution.
Closure of the ostium primum atrial septal defect followed repair of the left atrioventricular valve and was also achieved by an autologous or heterologous pericardial patch, always leaving the coronary sinus on the right atrial side.
The RVOT was explored from both the right atrium and the infundibular incision. Resection of obstructive right ventricular muscle bundles was performed. The pulmonary valve was sized by Hegar dilators. If the Z-score of the pulmonary valve was À2, the RVOT reconstruction was accomplished by either transannular patch or valved conduit interposition according to the surgeon's preference. More recently, insertion of a polytetrafluoroethylene (PTFE) monocusp valve was combined in cases of transannular patch reconstruction.
Statistical Analysis
Statistical analysis was conducted with the SAS-Statview-1998 statistical software, SAS Institute Inc (Cary, NC). Chi-square analysis was used to compare discrete variables between the groups of children who had staged repair and primary repair of CAVSD-TOF. Continuous variables, expressed 
RESULTS

Preoperative Data
Among the 33 children admitted to our center, there were 17 boys and 16 girls, with a mean weight of 15.7 AE 14.1 kg. Twenty-six (79%) had Down's syndrome, and 1 had Cantrell syndrome. Cyanosis was present in 15 cases (48%). A Rastelli type A CAVSD was diagnosed in 2 children, and all other 31 patients had the classical type C variant. Two patients had right aortic arch, 6 had persistent left superior vena cava to coronary sinus, and 1 had Wolff-ParkinsonWhite syndrome.
Surgical Strategy
Primary repair was achieved in 18 patients at a mean age of 32 AE 28.3 months, whereas 15 patients (45%) had initial palliation by systemic to pulmonary shunt (12) , right ventricular outflow patch (2), or percutaneous balloon dilatation of the pulmonary valve (1) . Mean age at palliation was 26.9 AE 33.5 months (range, 1.4-103.7 months). One patient died suddenly at home after systemic-to-pulmonary shunt, prior to complete repair. The remaining 14 patients had secondary complete repair at a mean of 55.1 AE 58.3 months (range, 1.2-210.7 months) after palliation.
Hospital Outcome
On the whole, 32 children had complete repair at a mean age of 54.9 AE 53.9 months (range, 4.6-224.4 months). There were no early deaths. Table 1 compares the preoperative and operative data between primary and staged repair.
Early reoperation was necessary in 6 patients including mediastinal reexploration for bleeding in 2 patients, diaphragm plication in 1, and implantation of a pacemaker for complete heart block in 3 patients (9%; Nos. 10, 12, and 15; Table 2 ). Patient No. 28 had urgent reoperation for severe aortic insufficiency on postoperative day 5. The noncoronary cusp of the aortic valve was torn and had successful repair by autologous pericardial patch; the aortic valve function of this patient remains normal 2 years postoperatively.
Follow-up
Follow-up assessment was available for 31 patients who had complete correction (97%). The mean follow-up was 69.3 AE 5.9 months (range, 0.2-282 months). During this period, there were 2 deaths. Patient No. 4 (Table 2 ) died 20 days after reoperation for residual ventricular septal defect and pulmonary stenosis with dilatation of RVOT. His postoperative course was complicated by mediastinitis and multiple organ failure. The other patient died at home while awaiting conduit replacement (patient No. 1). Both children had Down's syndrome and both had staged repair of TOF-CAVSD.
Actuarial survival was 96% AE 3.9% at 5 years and 85.9% AE 1.1% at 10 years (Figure 1 ). Among the 29 survivors, 55% were in class I, 38% in class II, 5% in class III, and 2% in class IV.
Role of RVOT Reconstruction
Right ventricular outflow tract obstruction was relieved by a transannular patch in 14 cases (42%), with a PTFE monocusp in 4 cases, by an infundibular patch with preservation of the pulmonary valve in 7 cases (21%), and a right ventricle-to-pulmonary artery valved conduit interposition was used in 11 cases (33%). The type of relief of RVOT did not influence survival (P ¼ .16). Use of a prosthetic conduit (P ¼ .82) did not affect surgical outcome (Figure 2 ).
Staged repair (P ¼ .05) and higher weight (P ¼ .05) at correction were possibly associated with an increased probability of death (Table 3 ).
Complications and Reoperations
Eight patients (25%) required late reoperations for conduit replacement (3), closure of residual ventricular septal defect (3), mitral valve replacement (1), and tricuspid valve replacement (1). Overall freedom from reoperation after complete repair was 69% at 5 years and 38% at 10 years. Freedom from reoperations after complete repair was 29% after 6 years in the staged repair group and 50.4% at 10 years in the primary repair group (P ¼ .11; Figure 3 ). Differences between the 2 groups were evident, although not statistically significant, probably due to the small size of the cohort.
Freedom from reinterventions at 10 years was 62.2% AE 20% in the no-conduit group compared with 14.0% AE 12.9% in the conduit group (P ¼ .05; Figure 4 ). Presence of trisomy 21 was an inverse risk factor for reintervention according to Cox proportional hazard (P ¼ .008; Table 4 ).
DISCUSSION
Tetralogy of fallot associated with CAVSD is an uncommon finding.
1,2 The current literature reports few studies with small cohorts. 3, 5, [8] [9] [10] [11] To our knowledge, our experience represents one of the largest cohorts with long-term follow-up.
The association of TOF and CAVSD was long considered a surgical challenge. 5, [8] [9] [10] [11] Mortality rate at correction ranged between 15% and 33%. 10, 12, 13 Recent reports confirm a reduction in mortality and morbidity after surgical correction. 3, 5, 8 These improvements can be attributed to several factors, including better diagnostic accuracy, perioperative care, and surgical approach.
Our study shows the following:
1. There was no hospital mortality at repair, and the actuarial survival was 86% at 10 years. These findings demonstrate that this anomaly can be corrected with low risk and favorable intermediate survival. Therefore, our data confirm the recent improvements in surgical repair of this complex lesion. 3, 5, 8, 12, 13 2. The type of RVOT obstruction relief did not affect surgical outcome. This finding is in contrast with previous recommendations about the mandatory use of a valved conduit to avoid pulmonary regurgitation particularly in the critical early postoperative period. 10 We suggest that in case of favorable anatomy (normal pulmonary artery size, good right ventricular function), the RVOT obstruction can be effectively relieved by transannular or limited infundibular patching. In our experience, avoidance of right ventricle-to-pulmonary artery conduit was associated with a significantly higher freedom from reintervention. Our current policy includes the construction of a PTFE monocusp valve to reduce early pulmonary regurgitation, yet realizing the short-term efficacy of this approach. 14, 15 3. Primary repair possibly improves long-term survival.
This finding is in accordance with the results described by Najm et al, 3 who concluded that primary repair is superior to staged repair. Previous recommendations for age at repair have been in the range of 4 to 6 years 2,4,16 ; palliation was endorsed in severely cyanotic infants to carry them through that age target. Our results show that repair at 2 years of age allows excellent outcome. Since 2000, our policy favors primary repair to avoid potential complications (eg, prolonged cyanosis, progressive ventricular hypertrophy, prolonged left ventricular volume overload, interstage mortality, and increasing atrioventricular valve regurgitation). 4. Presence of genetic syndrome was common in our cohort (80%). This finding confirms the recent knowledge about the relationship between trisomy 21 and congenital heart defects. 17, 18 However, in contrast to the experience of Karl 8 and Uretzky and colleagues, 4 trisomy 21 was not found to be a risk factor for death. Rather, Down's syndrome appeared a protective factor for freedom from reintervention.
This retrospective study has at least 2 limitations. First, it reports an experience across 15 years, during which important improvements in pre-and postoperative care have been achieved. Second, the small number of patients in some subgroups suggests a careful interpretation of data analysis and requires further confirmation.
CONCLUSION
Teratology of fallot-CAVSD can be corrected at low risk and good intermediate survival. Our results demonstrate that systematic use of right ventricle-to-pulmonary artery conduit can be avoided at least in cases of favorable anatomy. Transannular patching is a valid alternative for RVOT reconstruction and prevents multiple conduit replacement. 
